je.st
news
Tag: fourthquarter
Albany International Reports Fourth-Quarter Results
2014-02-11 12:00:32| Paper - Topix.net
MC gross profit margin decreased from 45.0 percent in 2012 to 41.7 percent in 2013.
Tags: results
international
reports
albany
LG Electronics Mobile Communications announces improved fourth-quarter 2013 financial results 2013
2014-02-11 07:44:42| Electronics - Topix.net
The LG Mobile Communications Company announced consolidated revenues shipping 13.2 million Smartphones during the fourth quarter of 2013, recording the highest quarterly sales in its history.
Tags: results
mobile
electronics
financial
3-2011 Fourth-Quarter, Year-End Reports: SC
2014-02-09 08:35:27| Steel - Topix.net
Metals USA Holdings Corp., Fort Lauderdale, Fla., reported net sales of $323.9 million for the fourth quarter, an increase of 32 percent compared to net sales of $245.3 million for the fourth quarter of 2009, but 6 percent lower than the $345.3 million in net sales for the previous quarter.
Tags: reports
reports fourthquarter
yearend
fourthquarter
Select Comfort Reports Fourth-Quarter and Full-Year 2013 Results
2014-02-06 08:14:40| Furniture - Topix.net
Generates Fourth-quarter Net Sales of $231 Million , a 5% Year-over-year increase Reports Fourth-quarter EPS of $0.12 and Full-year EPS of $1.08 on a GAAP basis Provides 2014 outlook MINNEAPOLIS -- -- Select Comfort Corporation today reported fourth-quarter and full-year 2013 results for the period ended Dec. 28, 2013 .
Tags: results
select
reports
comfort
Merck Announces Fourth-Quarter and Full-Year 2013 Financial Results
2014-02-05 13:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. Fourth-Quarter 2013 Non-GAAP EPS Increased by 6 Percent Over Prior Year to $0.88, Excluding Certain Items; GAAP EPS Decreased by 13 Percent to $0.26. Full-Year 2013 Non-GAAP EPS of $3.49, Excluding Certain Items; GAAP EPS of $1.47. Fourth-Quarter 2013 Worldwide Sales Were $11.3 Billion, a Decrease of 4 Percent Reflecting Unfavorable Impact of Patent Expiries and a 3 Percent Negative Impact from Foreign Exchange. Full-Year 2013 Worldwide Sales Were $44.0 Billion, a Decrease of 7 Percent Reflecting Unfavorable Impact of Patent Expiries and a 2 Percent Negative Impact from Foreign Exchange. Strong Full-Year Sales Growth for GARDASIL, REMICADE, SIMPONI, ISENTRESS, ZOSTAVAX and the Diabetes Franchise. Returned $11 Billion to Shareholders in 2013 Through Dividends and Share Repurchases. Accelerated Development Program for MK-3475, Including Announcement of Four Collaborations to Evaluate Novel Combination Regimens, Initiation of a Phase I Study in 20 New Cancer Types and Rolling Submission of a BLA to the FDA. 2014 Full-Year Non-GAAP EPS Target of $3.35 to $3.53, Excluding Certain Items; GAAP EPS Range of $2.15 to $2.47. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2013. Language: English Contact: MerckMedia:Kelley Dougherty, 908- 423-4291Steve Cragle, 908-423-3461orInvestors:Carol Ferguson, 908-423-4465Joe Romanelli, 908-423-5185 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
financial
announces
merck
Sites : [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] next »